JP2016540051A5 - - Google Patents

Download PDF

Info

Publication number
JP2016540051A5
JP2016540051A5 JP2016556693A JP2016556693A JP2016540051A5 JP 2016540051 A5 JP2016540051 A5 JP 2016540051A5 JP 2016556693 A JP2016556693 A JP 2016556693A JP 2016556693 A JP2016556693 A JP 2016556693A JP 2016540051 A5 JP2016540051 A5 JP 2016540051A5
Authority
JP
Japan
Prior art keywords
ring
alkyl
compound according
group
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016556693A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016540051A (ja
JP6563947B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/068152 external-priority patent/WO2015084842A1/en
Publication of JP2016540051A publication Critical patent/JP2016540051A/ja
Publication of JP2016540051A5 publication Critical patent/JP2016540051A5/ja
Application granted granted Critical
Publication of JP6563947B2 publication Critical patent/JP6563947B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016556693A 2013-12-02 2014-12-02 Ccr6化合物 Active JP6563947B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361910838P 2013-12-02 2013-12-02
US61/910,838 2013-12-02
PCT/US2014/068152 WO2015084842A1 (en) 2013-12-02 2014-12-02 Ccr6 compounds

Publications (3)

Publication Number Publication Date
JP2016540051A JP2016540051A (ja) 2016-12-22
JP2016540051A5 true JP2016540051A5 (enExample) 2018-01-18
JP6563947B2 JP6563947B2 (ja) 2019-08-21

Family

ID=53274030

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016556693A Active JP6563947B2 (ja) 2013-12-02 2014-12-02 Ccr6化合物

Country Status (13)

Country Link
US (4) US9340509B2 (enExample)
EP (1) EP3076968B1 (enExample)
JP (1) JP6563947B2 (enExample)
KR (1) KR102331833B1 (enExample)
CN (1) CN105960237B (enExample)
AU (1) AU2014360743C1 (enExample)
CA (1) CA2930148C (enExample)
EA (1) EA029826B1 (enExample)
ES (1) ES2735360T3 (enExample)
IL (1) IL245704B (enExample)
MX (1) MX2016007128A (enExample)
WO (1) WO2015084842A1 (enExample)
ZA (1) ZA201603167B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105960237B (zh) 2013-12-02 2020-03-31 凯莫森特里克斯股份有限公司 Ccr6化合物
KR20200037857A (ko) 2017-08-14 2020-04-09 알러간, 인코포레이티드 3,4-이치환된 3-시클로부텐-1,2-디온 및 그의 용도
CR20200464A (es) 2018-03-08 2021-04-14 Incyte Corp Compuestos diólicos de aminopirazina como inhibidores de pi3k-y
WO2020010003A1 (en) 2018-07-02 2020-01-09 Incyte Corporation AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS
WO2020086504A1 (en) 2018-10-23 2020-04-30 Daiichi Sankyo Company, Limited Biaryl derivative
CN117018202A (zh) * 2019-07-08 2023-11-10 上海交通大学医学院附属瑞金医院 趋化因子受体ccr6抑制剂在预防银屑病复发中的新应用
KR102890201B1 (ko) 2019-07-10 2025-11-24 케모센트릭스, 인크. Pd-l1 억제제로서의 인단
ES3068390T3 (en) 2019-10-16 2026-05-29 Chemocentryx Inc Heteroaryl-biphenyl amides for the treatment of pd-l1 diseases
AU2020368392B2 (en) 2019-10-16 2026-01-08 Chemocentryx, Inc. Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases
TWI904157B (zh) 2020-04-30 2025-11-11 瑞士商愛杜西亞製藥有限公司 Ccr6受體調節劑
MX2024002173A (es) * 2021-08-18 2024-03-26 Chemocentryx Inc Compuestos de arilsulfonilo como inhibidores de ccr6.
IL310368A (en) 2021-08-18 2024-03-01 Chemocentryx Inc Arylsulfonyl(hydroxy)piperidines as CCR6 inhibitors
WO2023057548A1 (en) 2021-10-07 2023-04-13 Idorsia Pharmaceuticals Ltd Ccr6 receptor modulators
JP2024539987A (ja) 2021-10-26 2024-10-31 イドルシア・ファーマシューティカルズ・リミテッド Ccr6受容体調節剤
ES3073199T3 (en) 2021-10-28 2026-07-09 Idorsia Pharmaceuticals Ltd Ccr6 receptor modulators

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3944553A (en) 1974-02-13 1976-03-16 Trw Inc. Bis quinoline peri acids
US4021409A (en) 1975-06-19 1977-05-03 The United States Of America As Represented By The Secretary Of The Air Force Thermally stable benzimidazonaphthyridine compositions
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
LU86084A1 (fr) 1985-09-20 1987-04-02 Faco Sa Apparei de massage electrique
US5102417A (en) 1985-11-07 1992-04-07 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4800882A (en) 1987-03-13 1989-01-31 Cook Incorporated Endovascular stent and delivery system
US4886062A (en) 1987-10-19 1989-12-12 Medtronic, Inc. Intravascular radially expandable stent and method of implant
WO1990013332A1 (en) 1989-05-11 1990-11-15 Cedars-Sinai Medical Center Stent with sustained drug delivery
EP0470246B1 (en) 1990-02-28 1995-06-28 Medtronic, Inc. Intralumenal drug eluting prosthesis
US5429634A (en) 1993-09-09 1995-07-04 Pdt Systems Biogenic implant for drug delivery and method
US5419760A (en) 1993-01-08 1995-05-30 Pdt Systems, Inc. Medicament dispensing stent for prevention of restenosis of a blood vessel
US6774278B1 (en) 1995-06-07 2004-08-10 Cook Incorporated Coated implantable medical device
US5833651A (en) 1996-11-08 1998-11-10 Medtronic, Inc. Therapeutic intraluminal stents
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6770729B2 (en) 2002-09-30 2004-08-03 Medtronic Minimed, Inc. Polymer compositions containing bioactive agents and methods for their use
JP2007537275A (ja) * 2004-05-12 2007-12-20 ケモセントリックス, インコーポレイテッド アリールスルホンアミド
AU2006204750C1 (en) * 2005-01-14 2012-11-01 Chemocentryx, Inc. Heteroaryl sulfonamides and CCR2
CN101511800B (zh) * 2006-07-14 2013-02-27 坎莫森特里克斯公司 三唑基苯基苯磺酰胺
PL2046762T3 (pl) * 2006-07-14 2011-07-29 Chemocentryx Inc Triazolilofenylobenzenosulfonamidy
WO2009008552A1 (en) 2007-07-11 2009-01-15 Taisho Pharmaceutical Co., Ltd. 8-aryl-4-alkylpyrrolo[2,3,4-de]quinolin-5(4h)-one and 8-aryl-4-alkyl-4,5-dihydropyrrolo[2,3,4-de]quinolin-5-ol derivatives
CA2692761C (en) * 2007-07-12 2013-04-30 Chemocentryx, Inc. Fused heteroaryl pyridyl and phenyl benzenesulfonamides as ccr2 modulators for the treament of inflammation
CN101790374A (zh) * 2007-08-01 2010-07-28 H.隆德贝克有限公司 Kcnq钾通道开放剂用于减轻多巴胺能系统受到干扰的障碍或病症的症状或治疗这种障碍或病症的用途
AU2009248774B2 (en) 2008-05-23 2012-05-31 Novartis Ag Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors
JP5599783B2 (ja) * 2008-05-30 2014-10-01 アムジエン・インコーポレーテツド Pi3キナーゼの阻害薬
RU2505539C2 (ru) 2008-12-23 2014-01-27 Эбботт Лэборетриз Антивирусные соединения
KR20120063515A (ko) 2009-09-09 2012-06-15 아빌라 테라퓨틱스, 인크. Pi3 키나제 억제제 및 이들의 용도
TWI487486B (zh) 2009-12-01 2015-06-11 Syngenta Participations Ag 以異唑啉衍生物為主之殺蟲化合物
US9284301B2 (en) * 2010-03-25 2016-03-15 Merck Sharp & Dohme Corp. Soluble guanylate cyclase activators
CN103347520A (zh) 2010-10-13 2013-10-09 波士顿大学管理委员会 用作癌症化学治疗的晚期sv40因子(lsf)的抑制剂
KR101985184B1 (ko) 2011-01-28 2019-06-03 주식회사 동진쎄미켐 신규한 유기염료 및 이의 제조방법
TW201311149A (zh) 2011-06-24 2013-03-16 Ishihara Sangyo Kaisha 有害生物防治劑
BR112014004275A2 (pt) 2011-08-25 2017-03-21 Syngenta Participations Ag derivados de isoxazolina como compostos inseticidas
FR2981935B1 (fr) 2011-10-28 2015-08-07 Galderma Res & Dev Nouveaux composes di-substitues de la diamino-3,4-cyclobutene-3-dione-1,2 utiles dans le traitement de pathologies mediees par des chimiokines.
FR2981934B1 (fr) * 2011-10-28 2013-12-20 Galderma Res & Dev Nouveaux composes di-substitues de la diamino-3,4-cyclobutene-3-dione-1,2 utiles dans le traitement de pathologies mediees par des chimiokines.
DK2820006T3 (da) 2012-02-29 2017-11-06 Chemocentryx Inc Pyrazol-1-yl benzen sulfonamider som ccr9 antagonister
CN105960237B (zh) 2013-12-02 2020-03-31 凯莫森特里克斯股份有限公司 Ccr6化合物

Similar Documents

Publication Publication Date Title
JP2019531279A5 (enExample)
AR123089A2 (es) Compuesto de piridinona
JP2017530959A5 (enExample)
JP2016540742A5 (enExample)
RU2017125025A (ru) Конденсированные кольцевые гетероарильные соединения и их применение в качестве ингибиторов trk
RU2016139257A (ru) Конденсированное гетероциклическое соединение и его применение для борьбы с вредителями
JP2015537008A5 (enExample)
JP2015535277A5 (enExample)
JP2017526727A5 (enExample)
JP2014521688A5 (enExample)
JP2016500661A5 (enExample)
JP2015504067A5 (enExample)
JP2010535722A5 (enExample)
JP2017506666A5 (enExample)
JP2018514518A5 (enExample)
JP2017514855A5 (enExample)
JP2013523763A5 (enExample)
JP2016506935A5 (enExample)
JP2018522033A5 (enExample)
RU2015146957A (ru) Производные доластатина 10 и ауристатинов
JP2017517512A5 (enExample)
JP2018527295A5 (enExample)
JP2012140432A5 (enExample)
JP2016501246A5 (enExample)
JP2018502137A5 (enExample)